Sphingolipid metabolism-related genes B4GALNT1 and CERS4 as prognostic biomarkers in lung adenocarcinoma
PLOS One · 2026
DOI: 10.1371/journal.pone.0340437 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Jieun Jeon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Medicine, Keimyung University, Daegu, Republic of Korea. Hauptthemen laut MEDLINE: Lung Neoplasms, Biomarkers, Tumor, Adenocarcinoma of Lung, Sphingolipids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Sphingolipid metabolism is an important component of various biological processes, particularly in cancer pathology. This metabolic pathway significantly influences the behavior of cancer cells by regulating growth, apoptosis, and survival. Although modulating sphingolipid metabolism has attracted attention as a novel therapeutic strategy, its complexity and specific mechanisms remain incompletely understood. In the current study, transcriptomic profiling was employed to compare the expression of sphingolipid metabolism-related genes between normal solid tissues and lung adenocarcinoma tissues. Additionally, Gene Ontology, Kyoto Encyclopedia of Genes and Genomes enrichment, and protein–protein interaction (PPI) analyses were performed to investigate the functional relevance of these genes. Twelve sphingolipid metabolism-related genes formed a highly interconnected core, suggesting their potential central role within the regulatory network. Four genes were found to be significantly correlated with overall survival. Notably, B4GALNT1 upregulation and CERS4 downregulation correlated with advanced tumor stage and metastasis. They also showed prognostic significance in Cox regression analyses, and these findings were consistently validated in an independent cohort. In vitro, within lung adenocarcinoma cell lines, B4GALNT1 knockdown and CERS4 overexpression suppressed cell proliferation, migration, and epithelial-to-mesenchymal transition, supporting their roles in lung adenocarcinoma progression. These findings highlight B4GALNT1 and CERS4 as potential prognostic biomarkers and therapeutic targets in lung adenocarcinoma, warranting further clinical investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Medicine, Keimyung University, Daegu, Republic of Korea.
- Department of Research, Keimyung University Dongsan Medical Center, Daegu, Republic of Korea.
- Department of Physiology, School of Medicine, Keimyung University, Daegu, Republic of Korea.
- Department of Anatomy, School of Medicine, Keimyung University, Daegu, Republic of Korea.
- Department of Biochemistry, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
- Institute of medical science, School of Medicine, Keimyung University, Daegu, Republic of Korea.
ORCID-Profile: Jieun Jeon, Jae-Hyung Park, Jae-Ho Lee, Woo-Jae Park, Shin Kim
Förderung
- National Research Foundation of Korea
Zitieren
APA
Jeon, J., Kang, J., Park, J. H., Lee, J. H., Kim, D. E., Park, W. J., & Kim, S. (2026). Sphingolipid metabolism-related genes B4GALNT1 and CERS4 as prognostic biomarkers in lung adenocarcinoma. PLOS One. https://doi.org/10.1371/journal.pone.0340437
Vancouver
Jeon J, Kang J, Park JH, Lee JH, Kim DE, Park WJ, et al. Sphingolipid metabolism-related genes B4GALNT1 and CERS4 as prognostic biomarkers in lung adenocarcinoma. PLOS One. 2026. doi:10.1371/journal.pone.0340437
BibTeX
@article{Jeon2026,
author = {Jeon, Jieun and Kang, Junho and Park, Jae-Hyung and Lee, Jae-Ho and Kim, Dong Eun and Park, Woo-Jae and Kim, Shin},
title = {Sphingolipid metabolism-related genes B4GALNT1 and CERS4 as prognostic biomarkers in lung adenocarcinoma},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0340437}
}
EUVIMED